"On Feb. 24, 2014, the U.S. Food and Drug Administration approved Myalept (metreleptin for injection) as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired "...
- Clinician Information:
Exubera Patient Information including How Should I Take
In this Article
- What is insulin inhalation (Exubera)?
- What are the possible side effects of insulin inhalation (Exubera)?
- What is the most important information I should know about insulin inhalation (Exubera)?
- What should I discuss with my health care provider before taking insulin inhalation (Exubera)?
- How should I take insulin inhalation (Exubera)?
- What happens if I miss a dose (Exubera)?
- What happens if I overdose (Exubera)?
- What should I avoid while taking insulin inhalation (Exubera)?
- What other drugs will affect insulin inhalation (Exubera)?
- Where can I get more information?
What should I discuss with my health care provider before taking insulin inhalation (Exubera)?
Before using this medicine, tell your doctor if you have kidney disease, liver disease, or lung disorders such as asthma or COPD (chronic obstructive pulmonary disease).
You should not use insulin inhalation if you have a lung disease that is not well controlled with medication or other treatments.
If you have type 1 diabetes, you should use this medication in addition to another long-acting type of insulin.
If you have type 2 diabetes, this may be the only medication you use to control your blood sugar, or your doctor may prescribe another long-acting insulin or diabetes medicine you take by mouth.
This medication is only part of a complete program of treatment that may also include diet, exercise, weight control, and testing your blood sugar. Follow your diet, medication, and exercise routines very closely. Changing any of these factors can affect your blood sugar levels.
If there are any changes in the brand, strength, or type of insulin you use, your dosage needs may change. Always check your medicine when it is refilled to make sure you have received the correct brand and type as prescribed by your doctor. Ask the pharmacist if you have any questions about the medicine given to you at the pharmacy.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
Insulin inhalation can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I take insulin inhalation (Exubera)?
Use insulin inhalation exactly as it was prescribed for you. Do not use it in larger doses or for longer than recommended by your doctor.
Your doctor may occasionally change your dose to make sure you get the best results from this medication.
If you use insulin inhalation as a meal-time insulin, use it no more than 10 minutes before eating the meal.
To be sure this medication is not causing certain side effects, your lung function will need to be tested on a regular basis. It is important that you not miss any scheduled visits to your doctor.
Continue using insulin inhalation if you have a cold or flu virus that causes upper respiratory symptoms (cough, sore throat, nasal congestion). Check your blood sugar carefully during a time of stress or illness, since this can also affect your glucose levels.
Insulin inhalation is a powder that is supplied in "dose blisters" on cards that are packaged in a clear plastic tray. This tray is sealed inside a foil pouch that also contains a moisture-absorbing preservative packet. The 1-milligram (mg) dose blisters are supplied on a card printed with green ink. The 3-mg dose blisters are supplied on a card printed with blue ink.
Each 1-milligram dose blister of insulin inhalation powder is equal to 3 units of injectable insulin and each 3-milligram dose blister is equal to 8 units of injectable insulin. Using three of the 1-mg dose blisters will not give you the same amount of medicine as one 3-mg dose blister. You may receive too much insulin when using three 1-mg dose blisters together, which could result in hypoglycemia.
If you are combining 1-mg and 3-mg dose blisters to get your correct dose of insulin, always use the least number of blisters possible. For example, if your dose is 4 mg, use a 1-mg blister and a 3-mg blister (a total of two blisters). Do not use four 1-mg blisters or you may receive too much of this medication
The inhaler unit supplied with this medication includes a base, a chamber, and a release unit. Each release unit may be used for up to 2 weeks before replacing. You may use the inhaler for up to 1 year before replacing it.
Store the medication at room temperature, away from moisture and heat. Do not refrigerate or freeze. Protect the medicine from moisture and humidity at all times. Do not store the medicine in a bathroom where you shower.
Once you have opened the foil pouch, keep the unused dose blisters in the pouch and use them within 3 months after opening the pouch. Keep the moisture-absorbing preservative packet contained in the foil pouch and do not open the packet or use its contents.
Additional Exubera Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find tips and advances in treatment.